Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07311122) titled 'Endocrine Therapy Base on 21-gene RS' on Dec. 16, 2025.
Study Type: Observational
Primary Sponsor: Gangnam Severance Hospital
Condition:
Breast Cancer
Intervention:
Diagnostic Test: Oncotype DX
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2026
Target Sample Size: 4000
To know more, visit https://clinicaltrials.gov/study/NCT07311122
Disclaimer: Curated by HT Syndication....